Entry Point Capital, LLC Mannkind Corp Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Entry Point Capital, LLC holds 24,804 shares of MNKD stock, worth $169,163. This represents 0.09% of its overall portfolio holdings.
Number of Shares
24,804Holding current value
$169,163% of portfolio
0.09%Shares
3 transactions
Others Institutions Holding MNKD
# of Institutions
244Shares Held
148MCall Options Held
1.62MPut Options Held
802K-
Black Rock Inc. New York, NY22.6MShares$154 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.6MShares$107 Million0.0% of portfolio
-
State Street Corp Boston, MA9.6MShares$65.5 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY9.16MShares$62.5 Million6.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$59.7 Million0.83% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.76B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...